HomePharma

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Life Sciences Times - April 30, 2026

Pharma

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Life Sciences Times - April 30, 2026

Pharma

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Life Sciences Times - April 30, 2026

Pharma

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Life Sciences Times - April 29, 2026

Pharma

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Life Sciences Times - April 28, 2026

Pharma

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute

Life Sciences Times - February 2, 2021 0

Pharma

Pfizer-BioNTech to produce 2 billion doses of Covid vaccine in 2021

Life Sciences Times - February 2, 2021 0

Pharma

Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

Life Sciences Times - February 1, 2021 0

Pharma

Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated

Life Sciences Times - February 1, 2021 0

Pharma

EU authorizes AstraZeneca/Oxford COVID-19 vaccine

Life Sciences Times - January 30, 2021 0

Pharma

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand

Life Sciences Times - January 29, 2021 0

Pharma

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Life Sciences Times - January 29, 2021 0

Pharma

Novavax Covid-19 vaccine found 89.3% effective

Life Sciences Times - January 29, 2021 0

Pharma

J&J single-shot Covid-19 vaccine shows 66% efficacy overall

Life Sciences Times - January 29, 2021 0

Pharma

Pfizer-BioNTech Covid vax neutralises UK, South Africa variants

Life Sciences Times - January 28, 2021 0

Pharma

Why so many people overuse antibiotics

Life Sciences Times - January 28, 2021 0

Pharma

200 million extra doses: Biden-led Covid-19 turnaround kicks off

Life Sciences Times - January 27, 2021 0

1...878889...91 Page 88 of 91

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

April 30, 2026

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

April 30, 2026

Moleculent Raises $20 Million to Expand Functional Profiling Platform

April 30, 2026

Komodo Health Names Paul Thomas Chief Financial Officer

April 30, 2026

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US